Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia
about
Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesisStatins: definitive translational researchMechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat StrainThe pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it--almostThematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversyInference to the best explanation and mechanisms in medicine.Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility.Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoproteinCholesterol in the retina: the best is yet to come.Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic strokeAtherogenic factors and their epigenetic relationshipsA systems biology approach to understanding atherosclerosis.ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5)Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms.Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9Cholesteryl ester transfer protein (CETP) I405V polymorphism and cardiovascular disease in eastern European Caucasians - a cross-sectional studyDyslipidemia: evidence of efficacy of the pharmacological and non-pharmacological treatment in the elderly.The "Mevalonate hypothesis": a cholesterol-independent alternative for the etiology of atherosclerosis.Fundamental research is the basis for understanding and treatment of many human diseases.Hyperlipidemia as a risk factor for cardiovascular disease.Dietary fats and health: dietary recommendations in the context of scientific evidenceAdvances in the management of hyperlipidemia-induced atherosclerosis.Lipid-lowering effects of ezetimibe and simvastatin in combination.A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.Phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to intracellular adhesion molecule-1.Waist-to-height ratio is independently associated with chronic kidney disease in overweight type 2 diabetic patients.Commentary: body weight and mortality in the late 19th century.The role of dyslipidemia on ocular surface, lacrimal and meibomian gland structure and function.Identifying progression related disease risk modules based on the human subcellular signaling networks.Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.In vivo veritas: Thrombosis mechanisms in animal models
P2860
Q24294300-666245F3-EFAC-4009-9092-7969FF677E16Q26851528-D6EF96C7-8CFC-403A-A0B6-0D749C87E7BEQ28066227-1B313C32-2685-4BC5-B616-AD50C3D19BFCQ28277233-B6D4FAC2-0470-4FC6-A343-FABB2694CAB8Q28305315-298D156C-AA85-4A53-8C6A-3B976C73A781Q30388212-A972A4FB-C9A9-49D6-B748-DC0422B7077CQ30436204-A7E55526-6293-4220-9AF3-30A9C0E17A11Q31055400-FD96F4EA-F334-4260-8EBA-3A824F104807Q33758267-35E32ABF-7648-40C3-A3E2-3B8F89B3C968Q34095488-A6CE0D6C-790B-4CC5-B56B-0927CFCEDB90Q34340360-D82EE8E0-56C2-477E-B32B-7B41FD4CBF1CQ34355117-57215ED7-CE3F-4A42-9CCC-48E31C8A83C5Q35541914-671F817F-EC28-49F0-BCD3-D86601433E84Q35673049-FD4CC46F-EB79-4251-A713-80BA1CEA9106Q35771131-1E87738F-BC3B-44A8-B51E-85D169048202Q36083105-C609EBA4-EBBF-4212-953E-E2E0A1FCD064Q36163667-09C4E0A3-7373-4B1D-A45F-3E7D3A2586E4Q36394541-23FD5F54-1A78-4952-BB25-95769D5BA851Q36522101-C1D0F483-0988-47A1-9C28-00B1EE7474BDQ36609968-37292790-D0CF-41AE-9D1A-C112F5A6726FQ36832940-B310A24C-C4CD-4671-956A-F0A7C5A612ACQ37104870-5C62382E-2970-4600-9FE1-9421940AA78EQ37859778-DCFFFC79-61C1-4D74-B1D1-CE4CEA5E0824Q38036194-7575D4EF-DA89-4773-BDF1-9B14C4026233Q39900686-209F0011-2D8F-46AB-B56F-3B4FE842898FQ47416565-FD343D28-7D7E-4C60-A9E6-CF680069D993Q47422165-1D9D2392-C8EE-4F26-AE66-C97B91B81111Q50514688-3B6473B8-FFCE-4BA4-99F2-73808062BF2CQ51024931-D1A9904E-F163-488C-B8CA-CB6891A27915Q51737068-CB510C54-97B9-4564-A23B-FF38667283C0Q58863655-3582C38A-B1F5-4D6C-AE16-702EE8730E26
P2860
Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Thematic review series: the pa ...... ing the role of hyperlipidemia
@ast
Thematic review series: the pa ...... ing the role of hyperlipidemia
@en
Thematic review series: the pa ...... ing the role of hyperlipidemia
@nl
type
label
Thematic review series: the pa ...... ing the role of hyperlipidemia
@ast
Thematic review series: the pa ...... ing the role of hyperlipidemia
@en
Thematic review series: the pa ...... ing the role of hyperlipidemia
@nl
prefLabel
Thematic review series: the pa ...... ing the role of hyperlipidemia
@ast
Thematic review series: the pa ...... ing the role of hyperlipidemia
@en
Thematic review series: the pa ...... ing the role of hyperlipidemia
@nl
P2860
P921
P3181
P1476
Thematic review series: the pa ...... ing the role of hyperlipidemia
@en
P2093
Daniel Steinberg
P2860
P304
P3181
P356
10.1194/JLR.R500010-JLR200
P407
P577
2005-10-01T00:00:00Z